PREPRINT (not peer reviewed)

Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: medRxiv
Date: 2024-07-12
Source: medRxiv
DOI: 10.1101/2024.07.11.24310147
PubMed: Unavailable

Authors

Nogueira M García-Hernández S Roberto GS Marques LZ.

Watch author

Derived topics and classifications

psilocybin Addiction Safety Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.Journal of addiction medicine · 2026-01-01 Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.Journal of addiction medicine · 2026-01-01